Vimarsana
Biggest News Aggregation in the World

Page 13 - Director Simon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Director Simon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Director Simon Today - Breaking & Trending Today

Xenon Pharmaceuticals (NASDAQ:XENE) Sees Unusually-High Trading Volume - Vimarsana News

Xenon Pharmaceuticals (NASDAQ:XENE) Sees Unusually-High Trading Volume

Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Rating) saw an uptick in trading volume on Monday . 333,165 shares changed hands during trading, a decline of 15% from the previous session’s volume of 392,663 shares.The stock last traded at $39.87 and had previously closed at $39.39. Analysts Set New Price Targets Several research firms […]

Source: wkrb13.com
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Average Recommendation of "Moderate Buy" by Analysts - Vimarsana News

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Average Recommendation of "Moderate Buy" by Analysts

Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Rating) have been given a consensus recommendation of “Moderate Buy” by the thirteen ratings firms that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating and ten have issued a buy rating on the company. The average twelve-month price […]

Source: wkrb13.com
Xenon Pharmaceuticals' (XENE) "Outperform" Rating Reaffirmed at Royal Bank of Canada - Vimarsana News

Xenon Pharmaceuticals' (XENE) "Outperform" Rating Reaffirmed at Royal Bank of Canada

Royal Bank of Canada restated their outperform rating on shares of Xenon Pharmaceuticals (NASDAQ:XENE – Get Rating) in a research note published on Wednesday, Benzinga reports. The firm currently has a $51.00 price target on the biopharmaceutical company’s stock. A number of other brokerages have also recently commented on XENE. Needham & Company LLC increased […]

Source: wkrb13.com
Sequans Communications (NYSE:SQNS) Raised to "Hold" at StockNews.com - Vimarsana News

Sequans Communications (NYSE:SQNS) Raised to "Hold" at StockNews.com

Royal Bank of Canada restated their outperform rating on shares of Xenon Pharmaceuticals (NASDAQ:XENE – Get Rating) in a report issued on Wednesday, Benzinga reports. The brokerage currently has a $51.00 price target on the biopharmaceutical company’s stock. Other equities research analysts have also recently issued reports about the company. The Goldman Sachs Group assumed […]

Pedal Power can do more to get people on bicycles | The Canberra Times - Vimarsana News

Pedal Power can do more to get people on bicycles | The Canberra Times

Letters To The Editor